Zymeworks BC Inc

Zymeworks BC Inc

ZYME - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.06B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zymeworks BC IncZymeworks BC Inc-14.2--135%-0.4
$40.80

Target Price by Analysts

31.9% upsideZymeworks BC Target Price DetailsTarget Price
$-18.04

Current Fair Value

158.3% downside

Overvalued by 158.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.06 Billion
Enterprise Value$-144,867,943,289.00
Earnings per Share$-1.08
Beta1.17
Outstanding Shares72,993,313

Return

Return on Equity-135.41%ROE
Return on Assets-27.41%
Return on Invested Capital-31.87%

Valuation & Multiples

P/E Ratio-14.16P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.03Price to Book Ratio
Enterprise Value to Revenue-57601.57
Enterprise Value to EBIT1.3
Enterprise Value to Net Income1
Total Debt to Enterprise-0.22
Debt to Equity0.4Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.57
Consensus analyst estimate
Revenue Estimate
$4.54 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.29
Consensus analyst estimate
Revenue Estimate
$227.39 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 51.37%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.44%▼ 91.42%
Total Invested$47.27M▼ 97.36%
Investors Holding32▼ 176.00%

About Zymeworks Inc

CEO: Ali Tehrani

Zymeworks BC Insider Information FAQ

Stockcircle tracks 4 top investors with a current 13F position in Zymeworks BC. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 4 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider sale for Zymeworks BC in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.